Akums Drugs and Pharmaceuticals, a contract development and manufacturing organisation (CDMO), has onboarded Amrut Medhekar as Chief Executive Officer (CEO) of its CDMO business.
He will report to Sanjeev Jain and Sandeep Jain, the Joint Managing Directors of Akums.
Before this, Medhekar was President of India Business at Wockhardt. In this role, he spearheaded significant growth initiatives. He also spent considerable time in his career at the Zydus Group, along with key roles at Novartis, JK Tyre and Industries, Life Medicare Biotech, Torrent Pharmaceuticals, and Ranbaxy.
He has an extensive experience in the pharmaceutical industry, spanning corporate strategy, business leadership, key account management, portfolio strategy, and supply management.
As per the company, his proven track record of leadership and innovation in the pharmaceutical sector positions him to drive its CDMO business to new heights.
On his appointment, Medhekar stated, “I am honored to join Akums Drugs, a company renowned for its innovation and manufacturing prowess in the pharmaceutical sector. I look forward to working closely with the talented team at Akums to drive growth, enhance operational efficiencies, and deliver exceptional value to our clients.”
Sandeep Jain and Sanjeev Jain, Managing Directors, Akums Drugs and Pharmaceuticals, said, “We are delighted to welcome Amrut Medhekar to our leadership team. With his extensive experience and proven track record, we are confident Akums will reach new heights and set industry benchmarks under his leadership.”
